Emory University’s Goizueta Alzheimer’s Disease Research Center (GADRC) has secured a five-year, $21.9 million grant renewal from the National Institute on Aging (NIA). The funding will support ongoing research, care initiatives, and community engagement focused on Alzheimer’s disease.
The GADRC was first designated as an NIH Alzheimer’s Disease Research Center in 2005. Since then, it has developed into a recognized center for translational research and outreach serving Georgia and the Southeast. The P30 Center Core grant is awarded through a competitive review process and provides federal backing for the center’s continued efforts.
“We’re honored to have our center’s impact and momentum recognized with this renewal,” said Allan Levey, MD, PhD, director of the GADRC and executive director of the Emory Goizueta Brain Health Institute. “The P30 grant enables us to continue accelerating Alzheimer’s disease research and help bring advances into the clinic.”
With this renewed support, GADRC plans to focus on early detection methods, biomarker development, new therapeutic strategies including clinical trials for prevention, precision medicine approaches aimed at improving care for all individuals, broad community engagement, and training future researchers and clinicians.
Leadership at the center includes Director Allan Levey along with Associate Directors James Lah, MD, PhD, and Todd Golde, PhD. The GADRC works in coordination with other programs within the Goizueta Brain Health Institute such as the Personalized Brain Health Initiative and Georgia Memory Net.
“This renewal is not just an endorsement of our past work—it’s a catalyst for what comes next,” said Todd Golde. “We’re building a future where Alzheimer’s is not only treatable, but preventable.”
James Lah added: “This continued support from NIA reflects the strength of Emory’s collaborative brain health ecosystem. It enables us to push the boundaries of discovery science while also addressing real-world needs in diagnosis, treatment and equitable access to care.”
The GADRC bears its name in recognition of The Goizueta Foundation’s philanthropic contributions that have supported Emory’s growth as a leader in brain health innovation.
The Emory Goizueta Brain Health Institute focuses on advancing innovation in prediction, prevention, and treatment related to brain health. Its team researches mechanisms behind brain diseases while developing new therapeutic strategies and biomarkers. More information about their work can be found at https://goizuetabrainhealth.emory.edu.
